S 5571 119th Congress
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Latest Action
Read twice and referred to the Committee on Finance.
Sponsors
![Sen. Blackburn, Marsha [R-TN]](https://bioguide.congress.gov/bioguide/photo/B/B001243.jpg)
Actions
2026-09-28T00:00:00
Read twice and referred to the Committee on Finance.
2026-09-28T00:00:00
Introduced in Senate
Track this bill on CivicBeacon
Get push notifications when this bill is updated, contact your reps, and take action.
